Four Complex Supply Chain Challenges To Just-In-Time Delivery

Explore Topics and Trends impacting today's markets

Just-in-time delivery – in which a manufacturer receives raw materials and begins production only when an order is placed – has dominated supply chain management for decades.

But recently, the logistics of that model have increasingly been tested by global challenges, including tariffs and sanctions, the COVID-19 pandemic, Russia’s invasion of Ukraine, and more.

To get some perspective on what this could mean for both companies and consumers in the days and years ahead, let’s start with some background on the supply chain strategy under pressure.

The Origins of Just-In-Time Delivery

In the decades following the Second World War, Japan grew tremendously. There were many reasons for this growth, among them the innovation of just-in-time delivery. After the war, cash-constrained Japanese companies couldn’t finance the acquisition of large inventories of commodities and component parts as easily as their American counterparts. As a result, they pioneered lean manufacturing that made the most efficient possible use of capital, buying only the inputs they needed and getting those inventories there at just the right moment. By the 1980s, Japan had world-beating manufacturing that spanned automobiles to electronics. 

And by the 1990s, this just-in-time, lean manufacturing ethos spread worldwide. With the collapse of the Soviet Union, the integration of China into the global economy, and GATT agreements that reduced tariffs, barriers to trade seemed a thing of the past; just-in-time manufacturing went worldwide, helping to keep a lid on inflation. Everything seemed to move along fairly smoothly until the past two years, but now the world is beset by logistical problems all along the supply chain. So, what went wrong with just-in-time delivery? 

The Challenges of Just-In-Time Delivery

Just-in-time delivery works well when an integrated global economy is functioning smoothly with few barriers to trade. However, over the past few years, the assumptions underlying lean manufacturing have been severely challenged for several reasons.

  1. Even before the pandemic struck, there was some movement toward diversification of supply lines stemming from the Sino-U.S. trade dispute in 2018. 
  2. In 2020, COVID lockdowns began to create severe supply chain disruptions. 
  3. At the same time, consumer spending shifted away from services toward manufactured goods, and demand for manufactured items began to outstrip the global economy’s ability to produce them. 
  4. Finally, in 2022, renewed COVID lockdowns in China deepened the world’s logistical challenges for manufactured goods at the same time as Russia’s invasion of Ukraine disrupted the supplies of key commodities. 

We now have a global economy that is more fragmented and less integrated, which poses severe challenges to the just-in-time model. So, where do we go from here? What happens to the just-in-time, lean manufacturing model? 

The Outlook of Just-In-Time Delivery

Both companies and governments are making strong moves to diversify supply chains but it’s a complicated and long process that may take years. In the short term, the world’s logistical issues might grow worse. China appears to be favoring a strategy of zero COVID over economic growth, which has global implications for the manufacturing and consumer product sectors. Meanwhile, the impact of the Russo-Ukrainian conflict on the commodity markets is just beginning to be felt.

Ultimately, consumers are likely to experience the world’s logistical challenges in the form of higher prices for manufactured goods, and companies may see reduced profit margins as input costs climb and they find it more challenging to get products to market. Just-in-time won’t disappear but making supply chains more resilient will likely come with increased costs.


 

 

OpenMarkets is an online magazine and blog focused on global markets and economic trends. It combines feature articles, news briefs and videos with contributions from leaders in business, finance and economics in an interactive forum designed to foster conversation around the issues and ideas shaping our industry.

All examples are hypothetical interpretations of situations and are used for explanation purposes only. The views expressed in OpenMarkets articles reflect solely those of their respective authors and not necessarily those of CME Group or its affiliated institutions. OpenMarkets and the information herein should not be considered investment advice or the results of actual market experience. Neither futures trading nor swaps trading are suitable for all investors, and each involves the risk of loss. Swaps trading should only be undertaken by investors who are Eligible Contract Participants (ECPs) within the meaning of Section 1a(18) of the Commodity Exchange Act. Futures and swaps each are leveraged investments and, because only a percentage of a contract’s value is required to trade, it is possible to lose more than the amount of money deposited for either a futures or swaps position. Therefore, traders should only use funds that they can afford to lose without affecting their lifestyles and only a portion of those funds should be devoted to any one trade because traders cannot expect to profit on every trade. BrokerTec Americas LLC (“BAL”) is a registered broker-dealer with the U.S. Securities and Exchange Commission, is a member of the Financial Industry Regulatory Authority, Inc. (www.FINRA.org), and is a member of the Securities Investor Protection Corporation (www.SIPC.org). BAL does not provide services to private or retail customers.. In the United Kingdom, BrokerTec Europe Limited is authorised and regulated by the Financial Conduct Authority. CME Amsterdam B.V. is regulated in the Netherlands by the Dutch Authority for the Financial Markets (AFM) (www.AFM.nl). CME Investment Firm B.V. is also incorporated in the Netherlands and regulated by the Dutch Authority for the Financial Markets (AFM), as well as the Central Bank of the Netherlands (DNB).

©2022 CME Group Inc. All rights reserved